The DOI matches its Crossref record.
Prostaglandin D2 pathway upregulation: Relation to asthma severity, control, and TH2 inflammation
Open accessAbstract
Background Bronchoalveolar lavage (BAL) fluid prostaglandin D2 (PGD2) levels are increased in patients with severe, poorly controlled asthma in association with epithelial mast cells (MCs). PGD2, which is generated by hematopoietic prostaglandin D synthase (HPGDS), acts on 3 G protein–coupled receptors, including chemoattractant receptor–homologous molecule expressed on TH2 lymphocytes (CRTH2) and PGD2 receptor 1 (DP1). However, much remains to be understood regarding the presence and activation of these pathway elements in asthmatic patients. Objective We sought to compare the expression and activation of PGD2 pathway elements in bronchoscopically obtained samples from healthy control subjects and asthmatic patients across a range of disease severity and control, as well as in relation to TH2 pathway elements. Methods Epithelial cells and BAL fluid were evaluated for HPGDS (quantitative real-time PCR/immunohistochemistry [IHC]) and PGD2 (ELISA/liquid chromatography mass spectrometry) in relation to levels of MC proteases. Expression of the 2 inflammatory cell receptors DP1 and CRTH2 was evaluated on luminal cells. These PGD2 pathway markers were then compared with asthma severity, level of control, and markers of TH2 inflammation (blood eosinophils and fraction of exhaled nitric oxide). Results Confirming previous results, BAL fluid PGD2 levels were highest in patients with severe asthma (overall P = .0001). Epithelial cell compartment HPGDS mRNA and IHC values differed among groups (P = .008 and P < .0001, respectively) and correlated with MC protease mRNA. CRTH2 mRNA and IHC values were highest in patients with severe asthma (P = .001 and P = .0001, respectively). Asthma exacerbations, poor asthma control, and TH2 inflammatory markers were associated with higher PGD2, HPGDS, and CRTH2 levels. Conclusion The current study identifies coordinated upregulation of the PGD2 pathway in patients with severe, poorly controlled, TH2-high asthma despite corticosteroid use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease
Kuruvilla, M. E., Lee, F. E.-H., & Lee, G. B. (2019) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-018-8712-1 · Cited by 1,228
The Dynamics of the Skin’s Immune System
Nguyen, A. V., & Soulika, A. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081811 · Cited by 694
Neutrophilic Inflammation in Asthma and Association with Disease Severity
Ray, A., & Kolls, J. K. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.07.003 · Cited by 546
Immunologic mechanisms in asthma
Boonpiyathad, T., Sözener, Z. C., Satitsuksanoa, P., & Akdis, C. A. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101333 · Cited by 489
Xue, L., Salimi, M., Panse, I., Mjösberg, J. M., McKenzie, A. N. J., Spits, H., Klenerman, P., & Ogg, G. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.10.056 · Cited by 475
Metadata
- Authors
- Fajt, M. L., Gelhaus, S. L., Freeman, B., Uvalle, C. E., Trudeau, J. B., Holguin, F., & Wenzel, S. E.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 131
- Issue
- 6
- Pages
- 1504-1512.e12
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2033050749
- Cited by
- 211
- References
- 0
- FWCI
- 11.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prostaglandin D2 pathway upregulation: Relation to asthma severity, control, and TH2 inflammation. https://app.cochat.ai/papers/10.1016/j.jaci.2013.01.035
- The paper
- Fajt, M. L., Gelhaus, S. L., Freeman, B., Uvalle, C. E., Trudeau, J. B., Holguin, F., & Wenzel, S. E. (2013). Prostaglandin D2 pathway upregulation: Relation to asthma severity, control, and TH2 inflammation. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2013.01.035
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.